nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ADRA1D—polycystic ovary syndrome	0.325	0.412	CbGaD
Dronedarone—ADRA1B—polycystic ovary syndrome	0.277	0.351	CbGaD
Dronedarone—ADRA1A—polycystic ovary syndrome	0.187	0.237	CbGaD
Dronedarone—HCN3—pituitary gland—polycystic ovary syndrome	0.00314	0.0459	CbGeAlD
Dronedarone—HCN3—adipose tissue—polycystic ovary syndrome	0.00313	0.0457	CbGeAlD
Dronedarone—HCN2—pituitary gland—polycystic ovary syndrome	0.00295	0.043	CbGeAlD
Dronedarone—HCN2—adipose tissue—polycystic ovary syndrome	0.00293	0.0428	CbGeAlD
Dronedarone—HCN2—adrenal gland—polycystic ovary syndrome	0.00263	0.0384	CbGeAlD
Dronedarone—HCN3—vagina—polycystic ovary syndrome	0.0026	0.038	CbGeAlD
Dronedarone—KCNK2—adrenal cortex—polycystic ovary syndrome	0.00213	0.031	CbGeAlD
Dronedarone—KCNK2—adipose tissue—polycystic ovary syndrome	0.00171	0.025	CbGeAlD
Dronedarone—CACNB3—endometrium—polycystic ovary syndrome	0.00164	0.0239	CbGeAlD
Dronedarone—CACNB4—vagina—polycystic ovary syndrome	0.0016	0.0234	CbGeAlD
Dronedarone—CACNB1—adipose tissue—polycystic ovary syndrome	0.00154	0.0225	CbGeAlD
Dronedarone—KCNK2—adrenal gland—polycystic ovary syndrome	0.00153	0.0224	CbGeAlD
Dronedarone—CACNB3—uterus—polycystic ovary syndrome	0.00151	0.0221	CbGeAlD
Dronedarone—CACNB3—pituitary gland—polycystic ovary syndrome	0.00148	0.0217	CbGeAlD
Dronedarone—CACNB3—adipose tissue—polycystic ovary syndrome	0.00148	0.0216	CbGeAlD
Dronedarone—KCNK2—vagina—polycystic ovary syndrome	0.00142	0.0208	CbGeAlD
Dronedarone—CYP3A4—urine—polycystic ovary syndrome	0.00139	0.0202	CbGeAlD
Dronedarone—CACNB1—adrenal gland—polycystic ovary syndrome	0.00138	0.0202	CbGeAlD
Dronedarone—CYP2D6—urine—polycystic ovary syndrome	0.00137	0.0199	CbGeAlD
Dronedarone—CACNB3—adrenal gland—polycystic ovary syndrome	0.00133	0.0193	CbGeAlD
Dronedarone—CACNB1—female gonad—polycystic ovary syndrome	0.00129	0.0188	CbGeAlD
Dronedarone—CACNB3—female gonad—polycystic ovary syndrome	0.00124	0.018	CbGeAlD
Dronedarone—CACNB3—vagina—polycystic ovary syndrome	0.00123	0.0179	CbGeAlD
Dronedarone—CACNA1D—adrenal cortex—polycystic ovary syndrome	0.00108	0.0157	CbGeAlD
Dronedarone—CACNB2—pituitary gland—polycystic ovary syndrome	0.000997	0.0145	CbGeAlD
Dronedarone—CACNB2—adrenal gland—polycystic ovary syndrome	0.000891	0.013	CbGeAlD
Dronedarone—CACNA1D—pituitary gland—polycystic ovary syndrome	0.000872	0.0127	CbGeAlD
Dronedarone—CACNB2—vagina—polycystic ovary syndrome	0.000826	0.012	CbGeAlD
Dronedarone—CACNA1C—pituitary gland—polycystic ovary syndrome	0.000805	0.0117	CbGeAlD
Dronedarone—CACNA1C—adipose tissue—polycystic ovary syndrome	0.000801	0.0117	CbGeAlD
Dronedarone—CACNA1D—adrenal gland—polycystic ovary syndrome	0.000779	0.0114	CbGeAlD
Dronedarone—CACNA1C—adrenal gland—polycystic ovary syndrome	0.000719	0.0105	CbGeAlD
Dronedarone—CACNA1D—endocrine gland—polycystic ovary syndrome	0.000675	0.00985	CbGeAlD
Dronedarone—ADRA1D—endocrine gland—polycystic ovary syndrome	0.00067	0.00977	CbGeAlD
Dronedarone—CACNA1C—vagina—polycystic ovary syndrome	0.000666	0.00972	CbGeAlD
Dronedarone—ADRB1—adipose tissue—polycystic ovary syndrome	0.000625	0.00912	CbGeAlD
Dronedarone—CACNA1C—endocrine gland—polycystic ovary syndrome	0.000623	0.00909	CbGeAlD
Dronedarone—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.000585	0.00854	CbGeAlD
Dronedarone—ALB—adrenal gland—polycystic ovary syndrome	0.000558	0.00813	CbGeAlD
Dronedarone—KCNH2—endometrium—polycystic ovary syndrome	0.00053	0.00773	CbGeAlD
Dronedarone—ADRA2C—endometrium—polycystic ovary syndrome	0.000523	0.00763	CbGeAlD
Dronedarone—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000494	0.00721	CbGeAlD
Dronedarone—KCNH2—uterus—polycystic ovary syndrome	0.000488	0.00712	CbGeAlD
Dronedarone—ADRB1—endocrine gland—polycystic ovary syndrome	0.000486	0.0071	CbGeAlD
Dronedarone—ADRA2C—uterus—polycystic ovary syndrome	0.000482	0.00703	CbGeAlD
Dronedarone—KCNH2—pituitary gland—polycystic ovary syndrome	0.000479	0.00699	CbGeAlD
Dronedarone—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000473	0.0069	CbGeAlD
Dronedarone—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000471	0.00687	CbGeAlD
Dronedarone—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000443	0.00647	CbGeAlD
Dronedarone—KCNH2—adrenal gland—polycystic ovary syndrome	0.000428	0.00625	CbGeAlD
Dronedarone—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000423	0.00617	CbGeAlD
Dronedarone—ADRA2A—endometrium—polycystic ovary syndrome	0.000417	0.00609	CbGeAlD
Dronedarone—KCNH2—female gonad—polycystic ovary syndrome	0.000399	0.00583	CbGeAlD
Dronedarone—KCNH2—vagina—polycystic ovary syndrome	0.000397	0.00579	CbGeAlD
Dronedarone—ADRA2C—female gonad—polycystic ovary syndrome	0.000394	0.00575	CbGeAlD
Dronedarone—ADRA2C—vagina—polycystic ovary syndrome	0.000392	0.00571	CbGeAlD
Dronedarone—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000385	0.00561	CbGeAlD
Dronedarone—ADRA2A—uterus—polycystic ovary syndrome	0.000384	0.00561	CbGeAlD
Dronedarone—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000377	0.00551	CbGeAlD
Dronedarone—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000376	0.00548	CbGeAlD
Dronedarone—KCNH2—endocrine gland—polycystic ovary syndrome	0.000371	0.00542	CbGeAlD
Dronedarone—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000337	0.00492	CbGeAlD
Dronedarone—ABCB1—embryo—polycystic ovary syndrome	0.000318	0.00463	CbGeAlD
Dronedarone—ADRA2A—female gonad—polycystic ovary syndrome	0.000314	0.00459	CbGeAlD
Dronedarone—ADRA2A—vagina—polycystic ovary syndrome	0.000312	0.00456	CbGeAlD
Dronedarone—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000292	0.00427	CbGeAlD
Dronedarone—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00026	0.0038	CbGeAlD
Dronedarone—CYP2D6—female gonad—polycystic ovary syndrome	0.000244	0.00355	CbGeAlD
Dronedarone—ABCB1—endometrium—polycystic ovary syndrome	0.000232	0.00339	CbGeAlD
Dronedarone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00023	0.00336	CbGeAlD
Dronedarone—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000226	0.0033	CbGeAlD
Dronedarone—ABCB1—uterus—polycystic ovary syndrome	0.000214	0.00312	CbGeAlD
Dronedarone—ABCB1—pituitary gland—polycystic ovary syndrome	0.00021	0.00307	CbGeAlD
Dronedarone—ABCB1—adipose tissue—polycystic ovary syndrome	0.000209	0.00306	CbGeAlD
Dronedarone—ABCB1—adrenal gland—polycystic ovary syndrome	0.000188	0.00274	CbGeAlD
Dronedarone—ABCB1—female gonad—polycystic ovary syndrome	0.000175	0.00256	CbGeAlD
Dronedarone—ABCB1—vagina—polycystic ovary syndrome	0.000174	0.00254	CbGeAlD
Dronedarone—ABCB1—endocrine gland—polycystic ovary syndrome	0.000163	0.00238	CbGeAlD
Dronedarone—Amiodarone—CYP1A1—polycystic ovary syndrome	6.92e-05	1	CrCbGaD
Dronedarone—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.85e-06	4.81e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	6.83e-06	4.79e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—YAP1—polycystic ovary syndrome	6.83e-06	4.79e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	6.82e-06	4.79e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	6.81e-06	4.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	6.81e-06	4.78e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	6.8e-06	4.77e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—IGF1—polycystic ovary syndrome	6.79e-06	4.77e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT2—polycystic ovary syndrome	6.79e-06	4.76e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	6.79e-06	4.76e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	6.77e-06	4.75e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	6.77e-06	4.75e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	6.75e-06	4.74e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.72e-06	4.72e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6.69e-06	4.7e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—GNAS—polycystic ovary syndrome	6.64e-06	4.66e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.62e-06	4.64e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—TH—polycystic ovary syndrome	6.6e-06	4.63e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6.59e-06	4.62e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—GNAS—polycystic ovary syndrome	6.58e-06	4.62e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.57e-06	4.61e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	6.56e-06	4.6e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NAMPT—polycystic ovary syndrome	6.56e-06	4.6e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.52e-06	4.58e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.51e-06	4.57e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.48e-06	4.55e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	6.48e-06	4.54e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.46e-06	4.54e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.46e-06	4.53e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	6.45e-06	4.53e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.43e-06	4.51e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	6.42e-06	4.51e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	6.41e-06	4.5e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.41e-06	4.49e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.38e-06	4.48e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NGFR—polycystic ovary syndrome	6.36e-06	4.47e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—POMC—polycystic ovary syndrome	6.32e-06	4.44e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—NCOR1—polycystic ovary syndrome	6.32e-06	4.44e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	6.32e-06	4.43e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	6.32e-06	4.43e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	6.32e-06	4.43e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PRL—polycystic ovary syndrome	6.31e-06	4.43e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.27e-06	4.4e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	6.26e-06	4.39e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	6.22e-06	4.37e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	6.21e-06	4.36e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	6.21e-06	4.35e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	6.15e-06	4.32e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.13e-06	4.3e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	6.12e-06	4.29e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.09e-06	4.27e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.08e-06	4.27e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	6.04e-06	4.24e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	6.04e-06	4.24e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	6.03e-06	4.23e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	6.02e-06	4.23e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	5.99e-06	4.21e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	5.99e-06	4.2e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.98e-06	4.2e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.98e-06	4.2e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	5.98e-06	4.2e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	5.94e-06	4.17e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.89e-06	4.13e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.88e-06	4.13e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	5.87e-06	4.12e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	5.87e-06	4.12e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.85e-06	4.11e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	5.85e-06	4.1e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.84e-06	4.1e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	5.75e-06	4.03e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.71e-06	4.01e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	5.68e-06	3.98e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.66e-06	3.97e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.66e-06	3.97e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	5.64e-06	3.95e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	5.62e-06	3.95e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	5.61e-06	3.93e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	5.6e-06	3.93e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	5.59e-06	3.92e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	5.56e-06	3.9e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.55e-06	3.9e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	5.55e-06	3.89e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	5.53e-06	3.88e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	5.51e-06	3.87e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.46e-06	3.83e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	5.46e-06	3.83e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.44e-06	3.81e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	5.42e-06	3.8e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	5.39e-06	3.78e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	5.36e-06	3.76e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	5.35e-06	3.75e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.31e-06	3.73e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.29e-06	3.71e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	5.28e-06	3.7e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	5.27e-06	3.7e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.23e-06	3.67e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—TH—polycystic ovary syndrome	5.21e-06	3.66e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.21e-06	3.65e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.2e-06	3.65e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	5.19e-06	3.64e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	5.17e-06	3.63e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	5.16e-06	3.62e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	5.14e-06	3.6e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	5.13e-06	3.6e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	5.12e-06	3.59e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.11e-06	3.58e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	5.07e-06	3.56e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	5.05e-06	3.54e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	4.97e-06	3.49e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.97e-06	3.49e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.94e-06	3.46e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	4.87e-06	3.42e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.86e-06	3.41e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.85e-06	3.4e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.8e-06	3.37e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	4.77e-06	3.34e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.76e-06	3.34e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	4.7e-06	3.3e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	4.66e-06	3.27e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.62e-06	3.24e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	4.6e-06	3.23e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—TH—polycystic ovary syndrome	4.57e-06	3.2e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	4.54e-06	3.18e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.54e-06	3.18e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.53e-06	3.18e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	4.53e-06	3.18e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.51e-06	3.16e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	4.47e-06	3.13e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.44e-06	3.12e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—INS—polycystic ovary syndrome	4.44e-06	3.12e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	4.44e-06	3.12e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	4.44e-06	3.11e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	4.43e-06	3.11e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.43e-06	3.11e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	4.41e-06	3.09e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.37e-06	3.07e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	4.35e-06	3.05e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—TH—polycystic ovary syndrome	4.3e-06	3.02e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.29e-06	3.01e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.29e-06	3.01e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	4.28e-06	3e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	4.26e-06	2.99e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	4.26e-06	2.99e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GNAS—polycystic ovary syndrome	4.25e-06	2.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.21e-06	2.96e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.19e-06	2.94e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	4.18e-06	2.94e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	4.18e-06	2.93e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.15e-06	2.91e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NCOR1—polycystic ovary syndrome	4.05e-06	2.84e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.05e-06	2.84e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	4.04e-06	2.83e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	4.01e-06	2.82e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	4e-06	2.81e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	3.98e-06	2.79e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.95e-06	2.77e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.93e-06	2.76e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.88e-06	2.73e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.88e-06	2.72e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.88e-06	2.72e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.88e-06	2.72e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.85e-06	2.7e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.84e-06	2.7e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.84e-06	2.7e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.82e-06	2.68e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.82e-06	2.68e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.8e-06	2.67e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.74e-06	2.62e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	3.73e-06	2.62e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	3.72e-06	2.61e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.69e-06	2.59e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.69e-06	2.59e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	3.68e-06	2.58e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	3.68e-06	2.58e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	3.66e-06	2.57e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.65e-06	2.56e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	3.63e-06	2.55e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.61e-06	2.53e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—INS—polycystic ovary syndrome	3.61e-06	2.53e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.59e-06	2.52e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.59e-06	2.52e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MTHFR—polycystic ovary syndrome	3.58e-06	2.51e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	3.55e-06	2.49e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.54e-06	2.48e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.54e-06	2.48e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.53e-06	2.48e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.53e-06	2.48e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.51e-06	2.46e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.5e-06	2.45e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.41e-06	2.39e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.39e-06	2.38e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	3.37e-06	2.36e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.36e-06	2.36e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.35e-06	2.35e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.3e-06	2.32e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.27e-06	2.29e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	3.26e-06	2.29e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.25e-06	2.28e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	3.25e-06	2.28e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.17e-06	2.23e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.15e-06	2.21e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.14e-06	2.2e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.14e-06	2.2e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	3.14e-06	2.2e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	3.03e-06	2.13e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	3.02e-06	2.12e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.98e-06	2.09e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.97e-06	2.08e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.96e-06	2.07e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.94e-06	2.06e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.92e-06	2.05e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.92e-06	2.05e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.9e-06	2.04e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—POMC—polycystic ovary syndrome	2.86e-06	2.01e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—INS—polycystic ovary syndrome	2.85e-06	2e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.81e-06	1.97e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.78e-06	1.95e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.77e-06	1.94e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.75e-06	1.93e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.74e-06	1.92e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.7e-06	1.9e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.57e-06	1.81e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.54e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.54e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.51e-06	1.76e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.51e-06	1.76e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.5e-06	1.75e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.4e-06	1.69e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.4e-06	1.68e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.36e-06	1.66e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.35e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.35e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.31e-06	1.62e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.3e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.23e-06	1.57e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.19e-06	1.53e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.07e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.05e-06	1.44e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.93e-06	1.36e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.92e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.91e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	1.75e-06	1.23e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.74e-06	1.22e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.62e-06	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.6e-06	1.12e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.57e-06	1.1e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.55e-06	1.08e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.54e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.42e-06	9.96e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.32e-06	9.25e-06	CbGpPWpGaD
